Crossmark

Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1016/j.reuma.2020.08.003

Published Print: 2022-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Tornero-Molina, Jesús

Alperi-López, Mercedes

Castellví, Ivan

de Agustín-de Oro, Juan José

Escudero, Alejandro

García-Vicuña, Rosario

González-Gay, Miguel Ángel

Hidalgo, Cristina

Rubio, Esteban

Sanmartí, Raimon

Casamira, Núria

Calvo-Alén, Jaime
Funding

Funding for this research was provided by:

Gebro Pharma
License Information

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2020-09-16
More Information

This article is maintained by: Elsevier

Article Title: Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2020.08.003

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below